Although there are only limited animal experiments suggesting that GLP-1 may lead to the development of psychiatric AEs (11), and there is no definitive evidence regarding the causal relationship between the use of GLP-1 RAs in humans and the development of psychiatric AEs, the fact that psychiatric AEs have occurred after the use of GLP-1 RAs suggests that these reports warrant increased clinical attention, early detection, and intervention
Gastrointestinal side effects from GLP-1 may also affect meal timing and insulin requirements, necessitating communication between patient and provider
Based on the matched data from the same individual including the abundance of bacterial genera and the plasma levels of identified BAs or metabolites, hierarchical clustering of Spearman correlations was performed with the software R 3.4.2 Heatmap package
Although no current evidence suggests that GLP-1RAs induce -catenin mutations or APC deficiencies, it is hypothesized that prolonged use of GLP-1RAs may foster the proliferative progression of colorectal cancer cells and pancreatic -cells, based on their mechanisms of action [99]
Both phentermine and semaglutide are powerful prescription medications